Home LiteratureArticle Details
PMID: 15113901 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Acute infection with Epstein-Barr virus targets and overwhelms the peripheral memory B-cell compartment with resting, latently infected cells.

Journal of virology ·Vol. 78 ·No. 10 ·2004-05-00 ·Pages 5194-204

Hochberg D, Souza T, Catalina M, Sullivan JL, Luzuriaga K, Thorley-Lawson DA

Abstract

In this paper we demonstrate that during acute infection with Epstein-Barr virus (EBV), the peripheral blood fills up with latently infected, resting memory B cells to the point where up to 50% of all the memory cells may carry EBV. Despite this massive invasion of the memory compartment, the virus remains tightly restricted to memory cells, such that, in one donor, fewer than 1 in 10(4) infected cells were found in the naive compartment. We conclude that, even during acute infection, EBV persistence is tightly regulated. This result confirms the prediction that during the early phase of infection, before cellular immunity is effective, there is nothing to prevent amplification of the viral cycle of infection, differentiation, and reactivation, causing the peripheral memory compartment to fill up with latently infected cells. Subsequently, there is a rapid decline in infected cells for the first few weeks that approximates the decay in the cytotoxic-T-cell responses to viral replicative antigens. This phase is followed by a slower decline that, even by 1 year, had not reached a steady state. Therefore, EBV may approach but never reach a stable equilibrium.

MeSH Terms
Acute Disease Adolescent Adult B-Lymphocytes/immunology,virology Herpesvirus 4, Human/physiology Humans Immunologic Memory Immunophenotyping Infectious Mononucleosis/immunology,virology T-Lymphocytes, Cytotoxic/immunology Virus Latency Virus Replication
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Hochberg Donna
Department of Pathology, Jaharis Building, Tufts University School of Medicine, 150 Harrison Avenue, Boston, MA 02111, USA.
Souza Tatyana
Catalina Michelle
Sullivan John L
Luzuriaga Katherine
Thorley-Lawson David A
References (46)
46 references, click to expand
  1. Malignant lymphoma in cottontop marmosets after inoculation with Epstein-Barr virus.
    Proc Natl Acad Sci U S A. 1973 Sep;70(9):2487-91 PMID: 4354852
  2. Epstein-barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients.
    J Exp Med. 1999 Aug 16;190(4):567-76 PMID: 10449527
  3. Quantitative evaluation of Epstein-Barr-virus-infected mononuclear peripheral blood leukocytes in infectious mononucleosis.
    N Engl J Med. 1977 Jan 20;296(3):132-4 PMID: 187934
  4. Epstein-Barr (EB) virus genome-containing, EB nuclear antigen-negative B-lymphocyte populations in blood in acute infectious mononucleosis.
    J Gen Virol. 1978 Mar;38(3):449-60 PMID: 204732
  5. Simultaneous presence of EBNA-positive and colony-forming cells in peripheral blood of patients with infectious mononucleosis.
    Int J Cancer. 1979 Jun 15;23(6):746-50 PMID: 223990
  6. Mitotic EBNA-positive lymphocytes in peripheral blood during infectious mononucleosis.
    Nature. 1980 Sep 25;287(5780):334-5 PMID: 6252472
  7. Plasmacytic differentiation of circulating Epstein-Barr virus-infected B lymphocytes during acute infectious mononucleosis.
    J Exp Med. 1981 Feb 1;153(2):235-44 PMID: 6264016
  8. Characterization of the major Epstein-Barr virus-specific RNA in Burkitt lymphoma-derived cells.
    J Virol. 1982 Feb;41(2):376-89 PMID: 6281455
  9. Transfection of a rearranged viral DNA fragment, WZhet, stably converts latent Epstein-Barr viral infection to productive infection in lymphoid cells.
    Proc Natl Acad Sci U S A. 1987 Mar;84(5):1332-6 PMID: 3029778
  10. The development and repertoire of B-1 cells (CD5 B cells).
    Immunol Today. 1991 Nov;12(11):389-91 PMID: 1723875
  11. A monkey model for Epstein Barr virus-associated lymphomagenesis in human acquired immunodeficiency syndrome.
    J Exp Med. 1992 Jul 1;176(1):281-6 PMID: 1319458
  12. Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo.
    J Gen Virol. 1992 Dec;73 ( Pt 12):3275-9 PMID: 1469366
  13. Germinal centers.
    Annu Rev Immunol. 1994;12:117-39 PMID: 8011279
  14. Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state.
    J Virol. 1994 Nov;68(11):7374-85 PMID: 7933121
  15. A novel form of Epstein-Barr virus latency in normal B cells in vivo.
    Cell. 1995 Feb 24;80(4):593-601 PMID: 7532548
  16. Detection of the latent form of Epstein-Barr virus DNA in the peripheral blood of healthy individuals.
    J Virol. 1996 May;70(5):3286-9 PMID: 8627812
  17. Persistent Epstein-Barr virus infection in the common marmoset (Callithrix jacchus).
    J Gen Virol. 1996 Jun;77 ( Pt 6):1173-80 PMID: 8683204
  18. Is EBV persistence in vivo a model for B cell homeostasis?
    Immunity. 1996 Aug;5(2):173-9 PMID: 8769480
  19. Mature B cells are required for acute splenic infection, but not for establishment of latency, by murine gammaherpesvirus 68.
    J Virol. 1996 Oct;70(10):6775-80 PMID: 8794315
  20. Lytic replication of Epstein-Barr virus in the peripheral blood: analysis of viral gene expression in B lymphocytes during infectious mononucleosis and in the normal carrier state.
    Blood. 1997 Mar 1;89(5):1665-77 PMID: 9057649
  21. Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response.
    J Exp Med. 1997 May 5;185(9):1605-17 PMID: 9151898
  22. Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell.
    J Virol. 1997 Jul;71(7):4882-91 PMID: 9188550
  23. Direct demonstration of persistent Epstein-Barr virus gene expression in peripheral blood of infected common marmosets and analysis of virus-infected tissues in vivo.
    J Gen Virol. 1997 Jun;78 ( Pt 6):1417-24 PMID: 9191939
  24. Germinal center development.
    Immunol Rev. 1997 Apr;156:111-26 PMID: 9280752
  25. EBV persistence in memory B cells in vivo.
    Immunity. 1998 Sep;9(3):395-404 PMID: 9768759
  26. The role of EBV in post-transplant malignancies: a review.
    J Clin Pathol. 2000 Apr;53(4):248-54 PMID: 10823119
  27. EBV persistence involves strict selection of latently infected B cells.
    J Immunol. 2000 Sep 15;165(6):2975-81 PMID: 10975805
  28. Cells expressing the Epstein-Barr virus growth program are present in and restricted to the naive B-cell subset of healthy tonsils.
    J Virol. 2000 Nov;74(21):9964-71 PMID: 11024124
  29. Human immunoglobulin variable region gene analysis by single cell RT-PCR.
    J Immunol Methods. 2000 Oct 20;244(1-2):217-25 PMID: 11033034
  30. Tonsillar memory B cells, latently infected with Epstein-Barr virus, express the restricted pattern of latent genes previously found only in Epstein-Barr virus-associated tumors.
    Proc Natl Acad Sci U S A. 2000 Oct 24;97(22):12250-5 PMID: 11035774
  31. EBV-infected B cells in infectious mononucleosis: viral strategies for spreading in the B cell compartment and establishing latency.
    Immunity. 2000 Oct;13(4):485-95 PMID: 11070167
  32. The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell.
    Immunity. 2000 Oct;13(4):497-506 PMID: 11070168
  33. Differential evolution and stability of epitope-specific CD8(+) T cell responses in EBV infection.
    J Immunol. 2001 Oct 15;167(8):4450-7 PMID: 11591771
  34. Epstein-Barr virus: exploiting the immune system.
    Nat Rev Immunol. 2001 Oct;1(1):75-82 PMID: 11905817
  35. The dispersal of mucosal memory B cells: evidence from persistent EBV infection.
    Immunity. 2002 May;16(5):745-54 PMID: 12049725
  36. Gamma-herpesvirus latency is preferentially maintained in splenic germinal center and memory B cells.
    J Exp Med. 2002 Nov 18;196(10):1363-72 PMID: 12438427
  37. Lack of deleterious somatic mutations in the CD95 gene of plasmablasts from systemic lupus erythematosus patients and autoantibody-producing cell lines.
    Eur J Immunol. 2002 Dec;32(12):3785-92 PMID: 12516573
  38. Epstein-Barr virus-infected B cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction.
    Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4730-5 PMID: 12665622
  39. Long-term latent murine Gammaherpesvirus 68 infection is preferentially found within the surface immunoglobulin D-negative subset of splenic B cells in vivo.
    J Virol. 2003 Aug;77(15):8310-21 PMID: 12857900
  40. Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo.
    Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):239-44 PMID: 14688409
  41. Infectious mononucleosis. Clinical manifestations in relation to EB virus antibodies.
    JAMA. 1968 Jan 15;203(3):205-9 PMID: 4864269
  42. Transformation of foetal human keukocytes in vitro by filtrates of a human leukaemic cell line containing herpes-like virus.
    Int J Cancer. 1968 Nov 15;3(6):857-66 PMID: 4894385
  43. The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV.
    Int J Cancer. 1971 Nov 15;8(3):443-50 PMID: 4332899
  44. Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells.
    J Exp Med. 1998 Nov 2;188(9):1679-89 PMID: 9802980
  45. CD5 expression in human B-cell populations.
    Immunol Today. 1999 Jul;20(7):312-6 PMID: 10379049
  46. EBV-determined nuclear antigen (EBNA)-positive cells in the peripheral blood of infectious mononucleosis patients.
    Int J Cancer. 1976 Jan 15;17(1):21-6 PMID: 55396
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2004-05-00
Pages
5194-204
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC400374
Subset
IM
Grants
NIAID NIH HHS · AI 49320 · United States
NCI NIH HHS · R01 CA065883 · United States
NIAID NIH HHS · P30 AI042845 · United States
NCI NIH HHS · CA 65883 · United States
NIAID NIH HHS · P01 AI049320 · United States
NIAID NIH HHS · AI 42845 · United States
NIAID NIH HHS · AI 18757 · United States
NIAID NIH HHS · R01 AI018757 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com